首页> 美国卫生研究院文献>Physiological Reports >Mechanism of inhibition of taurolithocholate‐induced retrieval of plasma membrane MRP2 by cyclic AMP and tauroursodeoxycholate
【2h】

Mechanism of inhibition of taurolithocholate‐induced retrieval of plasma membrane MRP2 by cyclic AMP and tauroursodeoxycholate

机译:环状AMP和牛磺脱氧胆酸抑制牛磺胆酸盐诱导的质膜MRP2回收。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Taurolithocholate (TLC) produces cholestasis by inhibiting biliary solute secretion in part by retrieving MRP2 from the plasma membrane (PM). Tauroursodeoxycholate (TUDC) and cAMP reverse TLC‐induced cholestasis by inhibiting TLC‐induced retrieval of MRP2. However, cellular mechanisms for this reversal are incompletely understood. Recently, we reported that TLC decreases PM‐MRP2 by activating PKCε followed by phosphorylation of myristoylated alanine‐rich C kinase substrate (MARCKS). Thus, cAMP and TUDC may reverse TLC‐induced cholestasis by inhibiting the style="fixed-case">TLC/ style="fixed-case">PKC ε/ style="fixed-case">MARCKS phosphorylation pathway. We tested this hypothesis by determining whether style="fixed-case">TUDC and/or style="fixed-case">cAMP inhibit style="fixed-case">TLC‐induced activation of style="fixed-case">PKCε and phosphorylation of style="fixed-case">MARCKS. Studies were conducted in HuH‐ style="fixed-case">NTCP cell line and rat hepatocytes. Activation of style="fixed-case">PKC ε was determined from the translocation of style="fixed-case">PKC ε to style="fixed-case">PM using a biotinylation method. Phosphorylation of style="fixed-case">MARCKS was determined by immunoblotting with a phospho‐ style="fixed-case">MARCKS antibody. style="fixed-case">TLC, but not style="fixed-case">cAMP and style="fixed-case">TUDC, activated style="fixed-case">PKC ε and increased style="fixed-case">MARCKS phosphorylation in HuH‐ style="fixed-case">NTCP as well in rat hepatocytes. Treatment with style="fixed-case">TUDC or style="fixed-case">cAMP inhibited style="fixed-case">TLC‐induced activation of style="fixed-case">PKCε and increases in style="fixed-case">MARCKS phosphorylation in both cell types. Based on these results, we conclude that the reversal of style="fixed-case">TLC‐induced cholestasis by style="fixed-case">cAMP and style="fixed-case">TUDC involves, at least in part, inhibition of style="fixed-case">TLC‐mediated activation of the style="fixed-case">PKCε/ style="fixed-case">MARCKS phosphorylation pathway.
机译:牛磺石胆酸盐(TLC)通过部分地通过从质膜(PM)检索MRP2抑制胆汁溶质分泌来产生胆汁淤积。牛磺去氧胆酸盐(TUDC)和cAMP通过抑制TLC诱导的MRP2检索逆转TLC诱导的胆汁淤积。但是,这种逆转的细胞机制尚不完全清楚。最近,我们报道了TLC通过激活PKCε继而将肉豆蔻酰化的富含丙氨酸的C激酶底物(MARCKS)磷酸化来降低PM-MRP2。因此,cAMP和TUDC可能通过抑制 style =“ fixed-case”> TLC / style =“ fixed-case”> PKC ε/ style来逆转TLC诱发的胆汁淤积=“ fixed-case”> MARCKS 磷酸化途径。我们通过确定 style =“ fixed-case”> TUDC 和/或 style =“ fixed-case”> cAMP 是否抑制 style =“ fixed-case”,对这一假设进行了检验> TLC -诱导 style =“ fixed-case”> PKC ε的激活和 style =“ fixed-case”> MARCKS 的磷酸化。研究是在HuH- style =“ fixed-case”> NTCP 细胞系和大鼠肝细胞中进行的。 style =“ fixed-case”> PKC ε的激活是根据 style =“ fixed-case”> PKC ε到 style =“ fixed-case”的易位确定的> PM 使用生物素化方法。通过使用磷酸化 span style =“ fixed-case”> MARCKS 抗体进行免疫印迹来确定 style =“ fixed-case”> MARCKS 的磷酸化。 style =“ fixed-case”> TLC ,但不是 style =“ fixed-case”> cAMP 和 style =“ fixed-case”> TUDC ,在HuH中激活了 style =“ fixed-case”> PKC ε并增强了 style =“ fixed-case”> MARCKS 磷酸化- style =“ fixed-case”> NTCP < / span>在大鼠肝细胞中也是如此。 style =“ fixed-case”> TUDC 或 style =“ fixed-case”> cAMP 的治疗抑制了 style =“ fixed-case”> TLC -诱导两种细胞类型中 style =“ fixed-case”> PKC ε的激活并增加 style =“ fixed-case”> MARCKS 磷酸化。根据这些结果,我们得出结论, style =“ fixed-case”> cAMP 和 style = “ fixed-case“> TUDC 至少部分涉及抑制 style =” fixed-case“> TLC 介导的 style =” fixed-case“>激活PKC ε/ style =“ fixed-case”> MARCKS 磷酸化途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号